UTRS News and Press, Minerva Surgical Inc. From 01/03/23

SANTA CLARA, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management team will present at the 41 st Annual J.P. ...

Women's health company Minerva Surgical ( NASDAQ: UTRS ) on Wednesday said it had appointed Todd Usen to succeed David Clapper as president and CEO, effective Jan. 2, 2023. Clapper has chosen to retire and will continue to work with the company under a consulting agreement for a year ...

SANTA CLARA, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that David Clapper, who has served as President and Chief Executive...

Minerva Surgical ( NASDAQ: UTRS ) said Tuesday it entered into a private placement, led by Accelmed, to sell 146,627,565 shares at $0.2046 per share, for proceeds totaling $30 million. Shares +23% aftermarket at $0.20. Following the offering, Accelmed will become...

SANTA CLARA, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it has entered into a share purchase agreement for the ...

SANTA CLARA, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the 34 th Annual Piper Sandler Healthcare Confer...

Minerva Surgical, Inc. (UTRS) Q3 2021 Earning Conference Call November 14, 2022 04:30 p.m. ET Company Representatives Dave Clapper - President, Chief Executive Officer Joel Jung - Chief Financial Officer Caroline Corner - Investor Relations Conference Call ...

press release ( NASDAQ: UTRS ): Q3 GAAP EPS of -$0.40 misses by $0.12 . Revenue of $12.6M (+0.7% Y/Y) in-line. Net loss in the third quarter of 2022 was $11.3 million, compared to a net loss of $3.2 million for the same period in 2021, and a net loss of $5.6 millio...

SANTA CLARA, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), today reported third quarter financial results for the period ended September...

SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it has changed the date of its previously announced earnings conference call. It wi...